向跌倒和晕厥专科服务机构转诊的住院病人:STOPPFall FRIDs的流行情况和去处方化模式回顾。

IF 2.4 3区 医学 Q3 PHARMACOLOGY & PHARMACY
D O'Donnell, T Zainal, K Malomo, N Fitzpatrick, C Rice, L Byrne, R Briggs, C Cunningham, R A Kenny, A H Lavan
{"title":"向跌倒和晕厥专科服务机构转诊的住院病人:STOPPFall FRIDs的流行情况和去处方化模式回顾。","authors":"D O'Donnell, T Zainal, K Malomo, N Fitzpatrick, C Rice, L Byrne, R Briggs, C Cunningham, R A Kenny, A H Lavan","doi":"10.1007/s00228-024-03776-5","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Falls are the commonest cause of accidental death in older people and the most frequent reason for their presentation to hospital. The Screening Tool of Older Persons Prescriptions in older adults with high falls risk (STOPPFall) facilitates deprescribing by providing a clear consensus on which medications are considered fall-risk-increasing drugs (FRIDs). This study aimed to determine the prevalence of STOPPFall FRIDs in inpatients referred to a falls and syncope service (FASS). Additionally, we aimed to analyse the impact of a dedicated FASS on deprescribing, both of FRIDs and of non-FRID medications.</p><p><strong>Methods: </strong>We conducted a retrospective observational study of all FASS inpatient consultations over a 6-month period (March-August 2021). Patients ≥ 65 years old were included. Medications on admission and discharge (following FASS assessment) were reviewed, with FRIDs identified using the STOPPFall deprescribing tool. The prevalence of FRIDs was defined as the proportion of patients who had at least one regular FRID prescribed on admission.</p><p><strong>Results: </strong>In total, 162 patients were included for review: 54.94% were (n = 89) female. The mean age of patients was 79.26 years (SD 7.45). STOPPFall FRIDs were prevalent, with 74.07% (120/162) on at least 1 regular FRID. Antidepressants (37.04%, n = 60) and diuretics (27.78%, n = 45) were the most frequently prescribed FRID classes. Of patients with a fracture, the mean number of FRIDs was 2.44 versus 1.56 in those without fracture (p = 0.01). At least one FRID was stopped in 35. 8% (n = 58) of patients. Following FASS review, 28.6% (n = 79) of all admission FRIDs were discontinued.</p><p><strong>Conclusion: </strong>STOPPFall FRIDs are prevalent in patients referred for inpatient FASS consultations. Presentations with acute fracture are associated with higher number of FRIDs on admission. Review by a dedicated hospital falls service leads to a reduction in FRIDs and deprescribing of anti-hypertensive medications.</p>","PeriodicalId":11857,"journal":{"name":"European Journal of Clinical Pharmacology","volume":" ","pages":"291-299"},"PeriodicalIF":2.4000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Inpatient referrals to a specialist falls and syncope service: prevalence of STOPPFall FRIDs and review of deprescribing patterns.\",\"authors\":\"D O'Donnell, T Zainal, K Malomo, N Fitzpatrick, C Rice, L Byrne, R Briggs, C Cunningham, R A Kenny, A H Lavan\",\"doi\":\"10.1007/s00228-024-03776-5\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>Falls are the commonest cause of accidental death in older people and the most frequent reason for their presentation to hospital. The Screening Tool of Older Persons Prescriptions in older adults with high falls risk (STOPPFall) facilitates deprescribing by providing a clear consensus on which medications are considered fall-risk-increasing drugs (FRIDs). This study aimed to determine the prevalence of STOPPFall FRIDs in inpatients referred to a falls and syncope service (FASS). Additionally, we aimed to analyse the impact of a dedicated FASS on deprescribing, both of FRIDs and of non-FRID medications.</p><p><strong>Methods: </strong>We conducted a retrospective observational study of all FASS inpatient consultations over a 6-month period (March-August 2021). Patients ≥ 65 years old were included. Medications on admission and discharge (following FASS assessment) were reviewed, with FRIDs identified using the STOPPFall deprescribing tool. The prevalence of FRIDs was defined as the proportion of patients who had at least one regular FRID prescribed on admission.</p><p><strong>Results: </strong>In total, 162 patients were included for review: 54.94% were (n = 89) female. The mean age of patients was 79.26 years (SD 7.45). STOPPFall FRIDs were prevalent, with 74.07% (120/162) on at least 1 regular FRID. Antidepressants (37.04%, n = 60) and diuretics (27.78%, n = 45) were the most frequently prescribed FRID classes. Of patients with a fracture, the mean number of FRIDs was 2.44 versus 1.56 in those without fracture (p = 0.01). At least one FRID was stopped in 35. 8% (n = 58) of patients. Following FASS review, 28.6% (n = 79) of all admission FRIDs were discontinued.</p><p><strong>Conclusion: </strong>STOPPFall FRIDs are prevalent in patients referred for inpatient FASS consultations. Presentations with acute fracture are associated with higher number of FRIDs on admission. Review by a dedicated hospital falls service leads to a reduction in FRIDs and deprescribing of anti-hypertensive medications.</p>\",\"PeriodicalId\":11857,\"journal\":{\"name\":\"European Journal of Clinical Pharmacology\",\"volume\":\" \",\"pages\":\"291-299\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2025-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Clinical Pharmacology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s00228-024-03776-5\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/11/23 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Clinical Pharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00228-024-03776-5","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/11/23 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

目的跌倒是导致老年人意外死亡的最常见原因,也是老年人入院的最常见原因。老年人高跌倒风险处方筛查工具(STOPPFall)通过对哪些药物被认为是增加跌倒风险的药物(FRIDs)达成明确共识,从而促进了处方的取消。本研究旨在确定转诊至跌倒与晕厥服务机构(FASS)的住院患者中 STOPPFall FRIDs 的患病率。此外,我们还旨在分析专门的 FASS 对取消 FRID 药物和非 FRID 药物处方的影响:我们对 6 个月内(2021 年 3 月至 8 月)所有 FASS 住院病人的就诊情况进行了回顾性观察研究。研究对象包括年龄≥ 65 岁的患者。研究人员对患者入院和出院时的用药情况进行了回顾(根据 FASS 评估结果),并使用 STOPPFall 去处方化工具确定了 FRID。FRID的流行率定义为入院时至少有一种常规FRID处方的患者比例:共有 162 名患者接受了审查:54.94% 为女性(n = 89)。患者平均年龄为 79.26 岁(标清 7.45)。患者普遍服用 STOPPFall FRIDs,74.07%(120/162)的患者至少定期服用一种 FRIDs。抗抑郁药(37.04%,n = 60)和利尿剂(27.78%,n = 45)是最常用的 FRID 药物。在骨折患者中,FRID 的平均次数为 2.44 次,而无骨折患者为 1.56 次(P = 0.01)。35.8%(n=58)的患者至少停用了一种 FRID。8%(n = 58)的患者停止了至少一次 FRID。FASS审查后,28.6%(n = 79)的入院FRID被终止:结论:STOPPFall FRID在FASS转诊的住院病人中很普遍。急性骨折患者入院时的 FRID 数量较高。由专门的医院跌倒服务机构进行复查可减少 FRID,并减少抗高血压药物的处方。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Inpatient referrals to a specialist falls and syncope service: prevalence of STOPPFall FRIDs and review of deprescribing patterns.

Purpose: Falls are the commonest cause of accidental death in older people and the most frequent reason for their presentation to hospital. The Screening Tool of Older Persons Prescriptions in older adults with high falls risk (STOPPFall) facilitates deprescribing by providing a clear consensus on which medications are considered fall-risk-increasing drugs (FRIDs). This study aimed to determine the prevalence of STOPPFall FRIDs in inpatients referred to a falls and syncope service (FASS). Additionally, we aimed to analyse the impact of a dedicated FASS on deprescribing, both of FRIDs and of non-FRID medications.

Methods: We conducted a retrospective observational study of all FASS inpatient consultations over a 6-month period (March-August 2021). Patients ≥ 65 years old were included. Medications on admission and discharge (following FASS assessment) were reviewed, with FRIDs identified using the STOPPFall deprescribing tool. The prevalence of FRIDs was defined as the proportion of patients who had at least one regular FRID prescribed on admission.

Results: In total, 162 patients were included for review: 54.94% were (n = 89) female. The mean age of patients was 79.26 years (SD 7.45). STOPPFall FRIDs were prevalent, with 74.07% (120/162) on at least 1 regular FRID. Antidepressants (37.04%, n = 60) and diuretics (27.78%, n = 45) were the most frequently prescribed FRID classes. Of patients with a fracture, the mean number of FRIDs was 2.44 versus 1.56 in those without fracture (p = 0.01). At least one FRID was stopped in 35. 8% (n = 58) of patients. Following FASS review, 28.6% (n = 79) of all admission FRIDs were discontinued.

Conclusion: STOPPFall FRIDs are prevalent in patients referred for inpatient FASS consultations. Presentations with acute fracture are associated with higher number of FRIDs on admission. Review by a dedicated hospital falls service leads to a reduction in FRIDs and deprescribing of anti-hypertensive medications.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
5.40
自引率
3.40%
发文量
170
审稿时长
3-8 weeks
期刊介绍: The European Journal of Clinical Pharmacology publishes original papers on all aspects of clinical pharmacology and drug therapy in humans. Manuscripts are welcomed on the following topics: therapeutic trials, pharmacokinetics/pharmacodynamics, pharmacogenetics, drug metabolism, adverse drug reactions, drug interactions, all aspects of drug development, development relating to teaching in clinical pharmacology, pharmacoepidemiology, and matters relating to the rational prescribing and safe use of drugs. Methodological contributions relevant to these topics are also welcomed. Data from animal experiments are accepted only in the context of original data in man reported in the same paper. EJCP will only consider manuscripts describing the frequency of allelic variants in different populations if this information is linked to functional data or new interesting variants. Highly relevant differences in frequency with a major impact in drug therapy for the respective population may be submitted as a letter to the editor. Straightforward phase I pharmacokinetic or pharmacodynamic studies as parts of new drug development will only be considered for publication if the paper involves -a compound that is interesting and new in some basic or fundamental way, or -methods that are original in some basic sense, or -a highly unexpected outcome, or -conclusions that are scientifically novel in some basic or fundamental sense.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信